alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
I 

112TH CONGRESS 

1ST SESSION H. R. 3453 

To amend the Endangered Species Act of 1973 to authorize permits for 

takings of wolves to protect from wolf depredation in States where 

wolf populations exceed the recovery goals in a recovery plan under 

that Act. 

IN THE HOUSE OF REPRESENTATIVES 

NOVEMBER 17, 2011 

Mr. BENISHEK (for himself, Mr. RIBBLE, and Mr. HUIZENGA of Michigan) 

introduced the following bill; which was referred to the Committee on 

Natural Resources 

A BILL 

To amend the Endangered Species Act of 1973 to authorize 

permits for takings of wolves to protect from wolf depredation in States where wolf populations exceed the recovery goals in a recovery plan under that Act. 

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled, 

3 SECTION 1. SHORT TITLE. 

4 This Act may be cited as the ‘‘State Management of 

5 Recovered Wolves Act’’. 


pwalker on DSK5TPTVN1PROD with BILLS
2 

•HR 3453 IH

1 SEC. 2. PERMITS FOR TAKINGS OF WOLVES TO PROTECT 

2 FROM WOLF DEPREDATION. 

3 Section 10(a) of the Endangered Species Act of 1973 

4 (16 U.S.C. 1539(a)) is amended by adding at the end the 

5 following: 

6 ‘‘(3) The Secretary shall permit, under such terms 

7 and conditions as the Secretary may prescribe, any State 

8 in which wolves are listed under section 4(c) to conduct 

9 lethal and non-lethal control of wolves in such State to 

10 protect from wolf depredations, if the number of wolves 

11 in the population of wolves in such State exceeds the goal 

12 for such population established by a recovery plan in effect 

13 under section 4(f).’’. 

Æ 


pwalker on DSK5TPTVN1PROD with BILLS
§ 764.6 Protective administrative measures. ( a ) *License Exception limitation.* As provided in § 740.2(b) of the EAR, all License Exceptions are subject to revision, suspension, or revocation.
( b ) *Revocation or suspension of licenses.* As provided in § 750.8 of the EAR, all licenses are subject to revision, suspension, or revocation.
( c ) *Temporary denial orders.* BIS may, in accordance with § 766.24 of the EAR, issue an order temporarily denying export privileges when such an order is necessary in the public interest to prevent the occurrence of an imminent violation.
( d ) *Denial based on criminal conviction.* BIS may, in accordance with § 766.25 of the EAR, issue an order denying the export privileges of any person who has been convicted of an offense specified in § 11(h) of the EAA.
**EXHIBIT      32.1**

**CERTIFICATION      PURSUANT TO**

**18      U.S.C. SECTION 1350**

**AS      ADOPTED PURSUANT TO**

**SECTION      906 OF THE SARBANES-OXLEY ACT OF 2002**

|                              |                                                                                                                                                                                                                                              |                                                  |
|-----------------------------------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|-------------------------------------------------------|
|                              | eROOMSYSTEM              TECHNOLOGIES, INC.                                                                                                                                                                                                  |
|                         |                                                                                                                                                                                                                                         |                                             |
| Date:              March 13, 2008 | By:                                                                                                                                                                                                                                     | /s/ David              A.              Gestetner |
|                              | Name: David              A. Gestetner                                                                                                                                                                                                        |
|                              | Title:  President,                Chief Executive Officer, Secretaryand Chairman of the Board of Directors         (Principal                Executive, Financial and Accounting Officer)  |

----
### SUBCHAPTER XV–A—MENTAL HEALTH AND DRUG TREATMENT ALTERNATIVES TO INCARCERATION PROGRAMS
Exhibit 32.1   Certification Pursuant to
18 U.S.C. Section 1350, as Adopted Pursuant to
Section 906 of the Sarbanes-Oxley Act of 2002 In connection with the Quarterly Report on Form 10-Q of Inland Western Retail Real Estate Trust, Inc. (the "Company") for the quarter ended September 30, 2008 as filed with the Securities and Exchange Commission on the date hereof (the "Report"), Michael J. OHanlon, as President and Chief Executive Officer of the Company, Steven P. Grimes, as Chief Operating Officer and Chief Financial Officer of the Company and James W. Kleifges as Chief Accounting Officer of the Company, each hereby certifies, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to his knowledge: (1)The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and(2)The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.  /s/ Michael J. OHanlonName:Michael J. OHanlonPresident and Chief Executive OfficerDate:November 13, 2008/s/ Steven P. GrimesName:Steven P. GrimesChief Operating Officer and
Chief Financial OfficerDate:November 13, 2008/s/ James W. KleifgesName:James W. KleifgesChief Accounting OfficerDate:November 13, 2008
_________________________________________ 

 

 

Order Michigan Supreme Court 

Lansing, Michigan 

June 26, 2006 Clifford W. Taylor,

 Chief Justice 

130605 Michael F. Cavanagh 

Elizabeth A. Weaver 

Marilyn Kelly 

Maura D. Corrigan 

PEOPLE OF THE STATE OF MICHIGAN, 

Plaintiff-Appellee, 

Robert P. Young, Jr. 

Stephen J. Markman,

 Justices 

v SC: 130605 

 COA: 258347 

Genesee CC: 04-013625-FC 

TYRESE COLEMAN BUGGS, 

 Defendant-Appellant. 

_________________________________________/ 

On order of the Court, the application for leave to appeal the January 12, 2006 

judgment of the Court of Appeals is considered, and it is DENIED, because we are not 

persuaded that the questions presented should be reviewed by this Court. 

l0619 

I, Corbin R. Davis, Clerk of the Michigan Supreme Court, certify that the 

foregoing is a true and complete copy of the order entered at the direction of the Court. 

June 26, 2006 

Clerk
§ 1.2 Procedure. ( a ) Application. The request for advice or interpretation should be submitted in writing (one original and two copies) to the Secretary of the Commission and should: ( 1 ) State clearly the question(s) that the applicant wishes resolved;
( 2 ) cite the provision of law under which the question arises; and
( 3 ) state all facts which the applicant believes to be material. In addition, the identity of the companies and other persons involved should be disclosed. Letters relating to unnamed companies or persons may not be answered. Submittal of additional facts may be requested prior to the rendering of any advice.
( b ) Compliance matters. If the request is for advice as to whether the proposed course of action may violate an outstanding order to cease and desist issued by the Commission, such request will be considered as provided for in § 2.41 of this chapter.
[44 FR 21624, Apr. 11, 1979, as amended at 44 FR 40638, July 12, 1979]
#### 209 West 48th St. Realty Corp., Respondent, v. Rose Offset Printing Corp. et al., Appellants.

Order unanimously affirmed, with $20 costs and disbursements, with leave to the defendants to answer within ten days after service of the order, with notice of entry thereof, on payment of said costs. No opinion. Present — Glennon, J. P., Dore, Cohn, Callahan and Van Voorhis, JJ.
NRC Public Meeting 

Seabrook Station Update on ASR

Rick Noble, NextEra Energy Seabrook

December 18, 2013
2

ASR Project

Cores

Petrography

Material 

Property Tests

Residual 

Reactivity Tests

Walkdowns& 

Monitoring

Extent of 

Condition 

Walkdowns

Visual 

Assessment

Crack Indexing

Monitoring

Crack Indexing

Expansion 

Measurements

Station 

Programs

Structural 

Monitoring

Aging 

Management

Structural 

Assessments

Assessment of 

ASR Impact

Study of CEB

Containment

Structural 

Testing

Anchor Test 

Program

Girder Series

Block Series

Beam Test 

Programs

Shear

Reinforcement 

Anchorage

Structural 

Evaluation

Seabrook Personnel MPR Associates UT Austin’s FSEL SGH

Overview of Seabrook ASR Project
3

Test Programs at FSEL
Exhibit 31.2  Certification Pursuant to pursuant to Rule 13a-14(a) or Rule 15d-14(a) of the Securities Exchange Act of 1934, as amended  I, Hui Lin, certify that:  1. I have reviewed this quarterly report on Form 10-Q of Aida Pharmaceuticals, Inc. (the "Company);  2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;  3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;  4. As the registrant's certifying officer, I am responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the registrant and I have:  a) designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;  b) designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under my supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;  c) evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and  d) disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the period covered by this report that has materially affected, or is reasonably likely to materially affect, the  registrant's internal control over financial reporting.  5. As the registrant's certifying officer, I have disclosed, based on my most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of registrant's board of directors (or persons performing the equivalent function):   a) all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and  b) any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.  /s/ Hui Lin Hui Lin Chief Financial Officer Date:  May 19, 2008  2
§ 990.52 Injury assessment—quantification. ( a ) *General.* In addition to determining whether injuries have resulted from the incident, trustees must quantify the degree, and spatial and temporal extent of such injuries relative to baseline.
( b ) *Quantification approaches.* Trustees may quantify injuries in terms of: ( 1 ) The degree, and spatial and temporal extent of the injury to a natural resource;
( 2 ) The degree, and spatial and temporal extent of injury to a natural resource, with subsequent translation of that adverse change to a reduction in services provided by the natural resource; or
( 3 ) The amount of services lost as a result of the incident.
( c ) *Natural recovery.* To quantify injury, trustees must estimate, quantitatively or qualitatively, the time for natural recovery without restoration, but including any response actions. The analysis of natural recovery may consider such factors as: ( 1 ) The nature, degree, and spatial and temporal extent of injury;
( 2 ) The sensitivity and vulnerability of the injured natural resource and/or service;
( 3 ) The reproductive and recruitment potential;
( 4 ) The resistance and resilience (stability) of the affected environment;
( 5 ) The natural variability; and
( 6 ) The physical/chemical processes of the affected environment.
(May 17, 1943.)

#### Irving Trust Company (formerly Irving Bank-Columbia Trust Company), as Trustee, Respondent, v. Violet E. Fernandez, Appellant, et al., Defendants. Irving Trust Company (formerly Irving Bank and Trust Company), as Trustee, Respondent, v. Violet E. Fernandez, Appellant, et al., Defendants.

Present — Carswell, Johnston, Adel, Taylor and Lewis, JJ.
## In the Court of Appeals Second Appellate District of Texas at Fort Worth

___________________________ No. 02

- 19

- 00304

- CR

___________________________

On Appeal from County Court at Law Cooke County, Texas Trial Court No. CR19

- 64649
Before Birdwell, Bassel, and Womack, JJ. Pe r Curiam Memorandum Opinion 

### D ENISHA 

### M ARIE 

### N ORTH 

### , Appellant

V



### . T HE 

### S TATE OF 

### T EXAS2 MEMORANDUM OPINION Appellant Denisha Marie North pleaded guilty to misdemeanor possession of marijuana. See Tex. Health & Safety Code Ann. § 481.121(b)(1). The trial court deferred adjudication and placed her on community supervision for eighteen months. North attempted to appeal. On December 10, 2019, North’s counsel filed a motion to withdraw indicating that “[i]t is Counsel’s opinion that Appellant does not wish to prosecute her appeal.” And on December 11, 2 019, the trial court filed an amended certification which stated that this “is a plea

- bargain case, and the defendant has NO right of appeal.” We abated the appeal and remanded the case to the trial court with instructions
to determine whether appellant desired to continue the appeal. On January 15, 2020, the trial court rendered an order stating that North “no longer wishes to pursue the appeal.” On January 22, 2020, we notified North and her attorney of the trial court’s
certification. See T ex. R. App. P. 25.2(a)(2). In our letter, we informed North that if she did not respond by February 3, 2020, showing grounds for continuing the appeal, the appeal could be dismissed. See Tex. R. App. P. 25.2(d), 44.3. North did not respond
to our letter . Accordingly, we grant counsel’s motion to withdraw and dismiss this appeal. See Tex. R. App. P. 25.2(a)(2), 43.2(f); Chavez v. State , 183 S.W.3d 675, 680 (Tex. Crim. App. 2006).
Per Curiam3 Do Not Publish Tex. R. App. P. 47.2(b)
Delivered: February 2 7, 2020
**Exhibit 32.2**

** **

**CERTIFICATION**

**PURSUANT TO SECTION 906 OF THE SARBANES-OXLEYACT OF 2002**

 

I, Chene Gardner, Principal Financial and AccountingOfficer of Vican Resources, Inc. (the “Company”) certify that:

 

1. I have reviewed the quarterly report on Form10-Q of the Company;

 

2. Based on my knowledge, this annual reportdoes not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made,in light of the circumstances under which such statements were made, not misleading with respect to the period covered by thisannual report; and

 

3. Based on my knowledge, the financial statements,and other financial information included in this annual report, fairly present in all material respects the financial condition,results of operations and cash flows of the Company as of, and for, the period presented in this annual report.

 

Date: November 21, 2011

 

/s/ Chene Gardner	

Chene Gardner

Principal Financial and Accounting Officer
**Exhibit 32.1**

 

**CERTIFICATIONPURSUANT TOSECTION 906 OF THE SARBANES-OXLEY ACT OF 2002**

** **

In connection with the Quarterly Report on Form 10-Q of ProUroCareMedical Inc. (the “Company”) for the quarter ended March 31, 2008 as filedwith the Securities and Exchange Commission on the date hereof (the “Report”),I, Richard C. Carlson, Chief Executive Officer of the Company, and I, RichardB. Thon, Chief Financial Officer of the Company, certify to the best of ourknowledge, pursuant to 18 U.S.C. 1350, that:

 

(1)           the Report fully complies with therequirements of Section 13(a) or 15(d) of the SecuritiesExchange Act of 1934; and

 

(2)           the information contained in the Report fairlypresents, in all material respects, the financial condition and results ofoperation of the Company.

 

 
| /s/ Richard C. Carlson  |   |
|-------------------------|--------|
| Richard C. Carlson      |
| Chief Executive Officer |
| May 7, 2008        |

 

 
| /s/ Richard. B. Thon    |   |
|-------------------------|--------|
| Richard B. Thon         |
| Chief Financial Officer |
| May 7, 2008        |

 

----
Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Department of Health and Human Services

###### National Institutes of Health

Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meeting.

The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.

*Name of Committee:*                         National Heart, Lung, and Blood Institute Special Emphasis Panel, Review of Research and Dissemination Projects (R18s).                     

*Date:*                         December 6, 2004.                    

*Time:*                         8 a.m. to 5 p.m.                    

*Agenda:*                         To review and evaluate grant applications.                    

*Place:*                         Sheraton Inner Harbor Hotel Baltimore, 300 South Charles Street, Baltimore, MD 21201.                    

*Contact Person:*                         Patricia A. Haggerty, PhD, Scientific Review Administrator, Review Branch, Division of Extramural Affairs, National Heart, Lung, and Blood Institute, National Institutes of Health, 6701 Rockledge Drive, Room 7188, Bethesda, MD 20892, 301/435-0280.                    

This notice is being published less than 15 days prior to the meeting due to the timing limitations imposed by the review and funding cycle.

(Catalogue of Federal Domestic Assistance Program Nos. 93.233, National Center for Sleep Disorders Research; 93.837, Heart and Vascular Diseases Research; 93.838, Lung Diseases Research; 93.839, Blood Diseases and Resources Research, National Institutes of Health, HHS)

Dated: November 10, 2004.

LaVerne Y. Stringfield,

Director, Office of Federal Advisory Committee Policy.

[FR Doc. 04-25582 Filed 11-17-04; 8:45 am]

BILLING CODE 4140-01-M
Exhibit 31.1

FORM 10-Q CERTIFICATION

I, Steven R. Williams, certify that:

I have reviewed this quarterly report on Form 10-Q of the Registrant;

2.	Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant of, and for, the periods presented in this report.

The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e) for the registrant and we have:

Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b)	Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and 

(c)	Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's third fiscal quarter of 2004 that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

5.	The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the board of directors of the Managing General Partner of the registrant;

(a)	all significant deficiencies and material weaknesses in the design or operation of internal controls over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

(b)	any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

 

Date:  November 10, 2004            
 /s/ Steven R. Williams                           

Steven R. Williams

Chief Executive Officer of the 

Managing General Partner of the Registrant